Context: Allergy symptoms that affect the eyes are common in adults and children worldwide, and are often associated with nasal allergy symptoms, prompting the term 'rhinoconjunctivitis' to ...

Unlock key insights into the Allergic Rhinoconjunctivitis Market! Download DelveInsight’s comprehensive report to explore market trends, pipeline analysis, and emerging therapies @ Allergic ...

The trial's primary efficacy endpoint will be the combined reduction in rhinoconjunctivitis symptoms and rescue medication use one year after the start of treatment, compared with placebo.

This Phase 3, double-blind, placebo-controlled, multicenter study analyzed ADR incidence in patients aged 18–50 years with medically confirmed grass pollen-induced allergic rhinoconjunctivitis ...

Jorien B. Wartna, from the Erasmus Medical Center in Rotterdam, Netherlands, and colleagues randomized 150 children (aged 6 to 18 years) with pollen-related allergic rhinoconjunctivitis to receive ...

A 36-year-old female patient presented with allergic rhinoconjunctivitis to pollens, had never had immunotherapy, but had a history of 4 episodes of anaphylaxis to dogs. She was treated with an ...

Release of a Corporate News, transmitted by DGAP - a company of EquityStory AG (Xetra: 549416 - Nachrichten) . The issuer / publisher is solely responsible for the content of this announcement.

Allergic rhinoconjunctivitis (ARC) is a symptomatic disorder of the upper airways caused by an immunoglobulin E (IgE)-mediated inflammatory response in sensitized subjects following allergen exposure.

Please provide your email address to receive an email when new articles are posted on . The incidence rate of atopic disease was 20.1 per 1,000 person-years for women who had a history of domestic ...

Suggested remit - To appraise the clinical and cost effectiveness of SGT320 within its marketing authorisation for treating allergic rhinitis or rhinoconjunctivitis caused by house dust mites. 27 ...

the 1 mg group patients had post-treatment a 39% lower median combined symptom and medication score than patients on placebo (p=0.035). While allergy symptoms were significantly lower in the 1 mg ...